✨ Your Portfolio is fetched and updated from zerodha.
Small Pharmaceuticals

Indegene Ltd.

INDGN

Get real time AI alerts about this company on your WhatsApp!
Market Cap
₹12,720 Cr.
P/E
28.53

Indegene Ltd.

  • Indegene
  • Syngene Internation.
  • Jubilant Pharmova

FAQs on Indegene Ltd. Shareprice

Indegene has given lower returns compared to its competitors.
Indegene has grown at ~-10.85% over the last 1yrs while peers have grown at a median rate of -8.91%

Indegene is not expensive.
Latest PE of Indegene is 28.54, while 3 year average PE is 38.38.
Also latest EV/EBITDA of Indegene is 21.27 while 3yr average is 26.84.

View FAQ's On Business

Growth Table

  • Indegene Ltd.
  • Syngene Internation.
  • Jubilant Pharmova

Balance Sheet

  • Indegene Ltd.
  • Syngene Internation.
  • Jubilant Pharmova

Balance Sheet Snapshot

No data available.

Fund Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end

Profit & Loss

  • Indegene Ltd.
  • Syngene Internation.
  • Jubilant Pharmova

Cash Flow

  • Indegene Ltd.
  • Syngene Internation.
  • Jubilant Pharmova

Cash Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.

Ratios

= Dominant Factor
  • Indegene Ltd.
  • Syngene Internation.
  • Jubilant Pharmova

Quarterly Results

  • Indegene Ltd.
  • Syngene Internation.
  • Jubilant Pharmova

Reverse DCF

locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF

FAQs on Indegene Ltd. Financials

Balance sheet of Indegene is strong.
It shouldn't have solvency or liquidity issues.

Yes, The net debt of Indegene is increasing.
Latest net debt of Indegene is -₹489.8 Crs as of Sep-25.
This is greater than Mar-25 when it was -₹749.2 Crs.

Yes, profit is increasing.
The profit of Indegene is ₹446 Crs for TTM, ₹407 Crs for Mar 2025 and ₹337 Crs for Mar 2024.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Indegene latest dividend payout ratio is 11.78% and 3yr average dividend payout ratio is 11.78%

Companies resources are allocated to majorly unproductive assets like Cash & Short Term Investments

View FAQ's On Shareholding
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech